COST EFFECTIVENESS OF DE-ESCALATION FROM MICAFUNGIN IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDA INFECTIONS COMPARED TO TRADITIONAL ESCALATION FROM FLUCONAZOLE

被引：0
|
作者：
Masterton, R.
Casamayor, M. [1 ]
Musingarimi, P.
Van Engen, A. [1 ]
Odufowora-Sita, O.
机构：
[1] Quintiles, Hoofddorp, Noord Holland, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.263
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A279 / A279
页数：1
相关论文
共 50 条
  • [11] MICAFUNGIN VS CASPOFUNGIN FOR THE TREATMENT OF SYSTEMIC CANDIDA INFECTIONS: A COST-EFFECTIVENESS ANALYSIS FOR GERMANY
    Felder, S.
    Grabe, K.
    Mayrhofer, T.
    Decker, S.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A426 - A427
  • [12] MICAFUNGIN VERSUS CASPOFUNGIN FOR THE TREATMENT OF SYSTEMIC CANDIDA INFECTIONS: A COST-EFFECTIVENESS ANALYSIS FOR SWITZERLAND
    Felder, S.
    Mayrhofer, T.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A275 - A275
  • [13] Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK
    Sidhu, M. K.
    van Engen, A. K.
    Kleintjens, J.
    Schoeman, O.
    Palazzo, M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 2049 - 2059
  • [14] A COST-EFFECTIVENESS ANALYSIS OF MICAFUNGIN VERSUS CASPOFUNGIN FOR TREATMENT OF SYSTEMIC CANDIDA INFECTIONS IN ITALY
    Sidhu, M. K.
    Van Engen, A. K.
    Switjnk, A. B.
    Concia, E.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [15] ROLE OF DE-ESCALATION OF ANTIBIOTIC THERAPY IN PATIENTS WITH URINARY TRACT INFECTIONS
    Subhasree, Bellam S.
    Joseph, Noyal Mariya
    Subramanian, Anandhalakshmi
    Al-Hakami, Ahmed Musa
    Kanungo, Reba
    [J]. ACTA MEDICA MEDITERRANEA, 2023, 39 (03): : 883 - 887
  • [16] Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
    Hiroshi Nakase
    Motohiro Esaki
    Fumihito Hirai
    Taku Kobayashi
    Katsuyoshi Matsuoka
    Minoru Matsuura
    Makoto Naganuma
    Masayuki Saruta
    Kiichiro Tsuchiya
    Motoi Uchino
    Kenji Watanabe
    Tadakazu Hisamatsu
    [J]. Journal of Gastroenterology, 2023, 58 : 313 - 345
  • [17] Advances in early breast cancer (EBC) care from the perspective of escalation and de-escalation
    Curigliano, Giuseppe
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S260 - S260
  • [18] Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021
    Nakase, Hiroshi
    Esaki, Motohiro
    Hirai, Fumihito
    Kobayashi, Taku
    Matsuoka, Katsuyoshi
    Matsuura, Minoru
    Naganuma, Makoto
    Saruta, Masayuki
    Tsuchiya, Kiichiro
    Uchino, Motoi
    Watanabe, Kenji
    Hisamatsu, Tadakazu
    TRADE Consensus Grp
    [J]. JOURNAL OF GASTROENTEROLOGY, 2023, 58 (04) : 313 - 345
  • [19] De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study
    Djamel Mokart
    Géraldine Slehofer
    Jérôme Lambert
    Antoine Sannini
    Laurent Chow-Chine
    Jean-Paul Brun
    Pierre Berger
    Ségolène Duran
    Marion Faucher
    Jean-Louis Blache
    Colombe Saillard
    Norbert Vey
    Marc Leone
    [J]. Intensive Care Medicine, 2014, 40 : 41 - 49
  • [20] De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study
    Mokart, Djamel
    Slehofer, Geraldine
    Lambert, Jerome
    Sannini, Antoine
    Chow-Chine, Laurent
    Brun, Jean-Paul
    Berger, Pierre
    Duran, Segolene
    Faucher, Marion
    Blache, Jean-Louis
    Saillard, Colombe
    Vey, Norbert
    Leone, Marc
    [J]. INTENSIVE CARE MEDICINE, 2014, 40 (01) : 41 - 49
12345